Alizapride C₁₆H₂₁N₅O₂

Active ingredient description

Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
A03FA05
Alizapride
A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives
Discover more medicines within A03FA05

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₆H₂₁N₅O₂
Molecular mass: 315.37 g/mol

External identifiers

CAS Substance: 59338-93-1
DrugBank Drug: DB01425
PubChem Compound: 135413504
RxNorm Ingredient: 17311
SNOMED-CT Concept: 724156007
Alizapride (substance)
UNII Identifier: P55703ZRZY
ALIZAPRIDE

Medicines

Alizapride is an active ingredient of these brands:

Brazil (BR)

  • SUPERAN as ALIZAPRIDE HYDROCHLORIDE

France (FR)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈